American Journal of Kidney Diseases
Volume 47, Issue 2 , Pages 317-323 , February 2006

The Impact of Accepting Living Kidney Donors With Mild Hypertension or Proteinuria on Transplantation Rates

Received 15 July 2005 ,Accepted 18 October 2005.

References 

  1. Canadian Institute for Health Information: CORR 2202 Preliminary Report. Available at: http://secure.cihi.ca/cihiweb/en/downloads/reports_corr2002prelim_e.pdf. Accessed: October 7, 2004
  2. Organ Procurement and Transplantation Network: Available at: http://www.optn.org/data/. Accessed: August 22, 2005
  3. Bia MJ , Ramos EL , Danovitch GM , et al.   Evaluation of living renal donors. The current practice of US transplant centers . Transplantation . 1995;60:322–327
  4. Gabolde M , Herve C , Moulin AM . Evaluation, selection, and follow-up of live kidney donors (A review of current practice in French renal transplant centres) . Nephrol Dial Transplant . 2001;16:2048–2052
  5. Lumsdaine JA , Wigmore SJ , Forsythe JL . Live kidney donor assessment in the UK and Ireland . Br J Surg . 1999;86:877–881
  6. Klag MJ , Whelton PK , Randall B , et al.   Blood pressure and end-stage renal disease in men . N Engl J Med . 1996;334:13–18
  7. Fox CS , Larson MG , Leip EP , et al.   Predictors of new-onset kidney disease in a community-based population . JAMA . 2004;291:844–850
  8. Haroun MK , Jaar BG , Hoffman SC , et al.   Risk factors for chronic kidney disease (A prospective study of 23,534 men and women in Washington County, Maryland) . J Am Soc Nephrol . 2003;14:2934–2941
  9. Iseki K , Iseki C , Ikemiya Y , et al.   Risk of developing end-stage renal disease in a cohort of mass screening . Kidney Int . 1996;49:800–805
  10. Iseki K , Ikemiya Y , Fukiyama K . Blood pressure and risk of end-stage renal disease in a screened cohort . Kidney Int Suppl . 1996;55:S69–S71
  11. Iseki K , Ikemiya Y , Iseki C , et al.   Proteinuria and the risk of developing end-stage renal disease . Kidney Int . 2003;63:1468–1474
  12. Stock PG . The year in review—ATC 2002 . Am J Transplant . 2003;3:373–380
  13. Textor SC , Taler SJ , Driscoll N , et al.   Blood pressure and renal function after kidney donation from hypertensive living donors . Transplantation . 2004;78:276–282
  14. Steiner RW , Gert B . Ethical selection of living kidney donors . Am J Kidney Dis . 2000;36:677–686
  15. Steiner RW . Risk appreciation for living kidney donors (Another new subspecialty?) . Am J Transplant . 2004;4: 694–597
  16. Ross LF , Glannon W , Josephson M , et al.   Should all living kidney donors be treated equally? . Transplantation . 2004;74:418–426
  17. Weisstuch JM , Dworkin LD . Does essential hypertension cause end-stage renal disease? . Kidney Int Suppl . 1992;41:S33–S37
  18. Kincaid-Smith P . Hypothesis (Obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled ‘hypertensive nephrosclerosis.’) . J Hypertens . 2004;22:1051–1055
  19. Perneger TV , Klag MJ , Feldman HI , et al.   Projections of hypertension-related renal disease in middle-aged residents of the United States . JAMA . 1993;269:1272–1277
  20. Coresh J , Astor BC , Greene T , et al.   Prevalence of chronic kidney disease and decreased kidney function in the adult US population (Third National Health and Nutrition Examination Survey) . Am J Kidney Dis . 2003;41:1–12
  21. Coresh J , Astor B , Sarnak MJ . Evidence for increased cardiovascular disease risk in patients with chronic kidney disease . Curr Opin Nephrol Hypertens . 2004;13:73–81
  22. Go AS , Chertow GM , Fan D , et al.   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization . N Engl J Med . 2004;351:1296–1305
  23. Foley RN , Murray AM , Li S , et al.   Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 . J Am Soc Nephrol . 2005;16:489–495
  24. Najarian JS , Chavers BM , McHugh LE , et al.   20 Years or more of follow-up of living kidney donors . Lancet . 1992;340:807–810
  25. Fehrman-Ekholm I , Duner F , Brink B . No evidence of accelerated loss of kidney function in living kidney donors (Results from a cross-sectional follow-up) . Transplantation . 2001;72:444–449
  26. Gossmann J , Wilhelm A , Kachel HG . Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center . Am J Transplant . 2005;5:2417–2425
  27. Hakim RM , Goldszer RC , Brenner BM . Hypertension and proteinuria (Long-term sequelae of uninephrectomy in humans) . Kidney Int . 1984;25:930–936
  28. Williams SL , Oler J , Jorkasky DK . Long-term renal function in kidney donors (A comparison of donors and their siblings) . Ann Intern Med . 1986;105:1–8
  29. Saran R , Marshall SM , Madsen R , et al.   Long-term follow-up of kidney donors (A longitudinal study) . Nephrol Dial Transplant . 1997;12:1615–1621
  30. Goldfarb DA , Matin SF , Braun WE , et al.   Renal outcome 25 years after donor nephrectomy . J Urol . 2001;166:2043–2047
  31. Ramcharan T , Matas AJ . Long-term (20-37 years) follow-up of living kidney donors . Am J Transplant . 2002;2:959–964
  32. Delmonico FL , Morrissey PE , Lipkowitz GS , et al.   Donor kidney exchanges . Am J Transplant . 2004;4:1628–1634
  33. Takemoto SK , Zeevi A , Feng S , et al.   National conference to assess antibody-mediated rejection in solid organ transplantation . Am J Transplant . 2004;4:1003–1011
  34. Jordan S , Cunningham-Rundles C , McEwan R . Utility of intravenous immune globulin in kidney transplantation (Efficacy, safety, and cost implications) . Am J Transplant . 2003;3:653–664
  35. Segev D , Gentry SE , Melancon JK . Characterization of waiting times in a simulation of kidney paired donation . Am J Transplant . 2005;5:2448–2456
  36. Joffres MR , Ghadirian P , Fodor JG , et al.   Awareness, treatment, and control of hypertension in Canada . Am J Hypertens . 1997;10:1097–1102
  37. Joffres MR , Hamet P , MacLean DR , et al.   Distribution of blood pressure and hypertension in Canada and the United States . Am J Hypertens . 2001;14:1099–1105

 Originally published online as doi:10.1053/j.ajkd.2005.10.012 on December 27, 2005.Support: Dr Garg is supported by a Canadian Institutes of Health Research Clinician Scientist Award. Potential conflicts of interest: None.

PII: S0272-6386(05)01610-0

doi: 10.1053/j.ajkd.2005.10.012

American Journal of Kidney Diseases
Volume 47, Issue 2 , Pages 317-323 , February 2006

Article Tools

* Image Usage & Resolution